(RTTNews) - Below are the earnings highlights for Biomarin Pharmaceutical Inc. (BMRN):
-Earnings: -$29.2 million in Q2 vs. -$37.4 million in the same period last year. -EPS: -$0.16 in Q2 vs. -$0.21 in the same period last year. -Analysts projected -$0.11 per share -Revenue: $429.5 million in Q2 vs. $387.8 million in the same period last year.
-Guidance: Full year revenue guidance: $1850 - $1950 Mln
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.